These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 31731173)

  • 1. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
    Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
    J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock.
    Hammond DA; Cullen J; Painter JT; McCain K; Clem OA; Brotherton AL; Chopra D; Meena N
    J Intensive Care Med; 2019; 34(11-12):910-916. PubMed ID: 28820036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
    Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
    Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
    J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
    Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
    Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The initial resuscitation of septic shock.
    Cinel I; Kasapoglu US; Gul F; Dellinger RP
    J Crit Care; 2020 Jun; 57():108-117. PubMed ID: 32135409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock.
    Roberts RJ; Miano TA; Hammond DA; Patel GP; Chen JT; Phillips KM; Lopez N; Kashani K; Qadir N; Cairns CB; Mathews K; Park P; Khan A; Gilmore JF; Brown ART; Tsuei B; Handzel M; Chang AL; Duggal A; Lanspa M; Herbert JT; Martinez A; Tonna J; Ammar MA; Nazer LH; Heavner M; Pender E; Chambers L; Kenes MT; Kaufman D; Downey A; Brown B; Chaykosky D; Wolff A; Smith M; Nault K; Gong MN; Sevransky JE; Lat I;
    Crit Care Med; 2020 Oct; 48(10):1445-1453. PubMed ID: 32706559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of second-line vasopressors for the treatment of septic shock.
    Lam SW; Barreto EF; Scott R; Kashani KB; Khanna AK; Bauer SR
    J Crit Care; 2020 Feb; 55():48-55. PubMed ID: 31706118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Norepinephrine Weight-Based Dosing Compared With Non-Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock.
    Vadiei N; Daley MJ; Murthy MS; Shuman CS
    Ann Pharmacother; 2017 Mar; 51(3):194-202. PubMed ID: 27886982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
    Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
    JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of vasopressor initiation and mortality in septic shock: a cohort study.
    Beck V; Chateau D; Bryson GL; Pisipati A; Zanotti S; Parrillo JE; Kumar A;
    Crit Care; 2014 May; 18(3):R97. PubMed ID: 24887489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function.
    Taylor A; Jones T; Forehand CC; Smith SE; Dykes H; Newsome AS
    J Pharm Pract; 2022 Dec; 35(6):879-885. PubMed ID: 33977793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
    Bauer SR; Sacha GL; Reddy AJ
    Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
    Wu JY; Stollings JL; Wheeler AP; Semler MW; Rice TW
    Ann Pharmacother; 2017 Jan; 51(1):13-20. PubMed ID: 27630192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin versus norepinephrine infusion in patients with septic shock.
    Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
    N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
    Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
    Hammond DA; McCain K; Painter JT; Clem OA; Cullen J; Brotherton AL; Chopra D; Meena N
    J Intensive Care Med; 2019 Oct; 34(10):805-810. PubMed ID: 28618919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressors for hypotensive shock.
    Gamper G; Havel C; Arrich J; Losert H; Pace NL; Müllner M; Herkner H
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD003709. PubMed ID: 26878401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selepressin, a novel selective vasopressin V
    Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
    Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A time-sensitive analysis of the prognostic utility of vasopressor dose in septic shock.
    Chotalia M; Matthews T; Arunkumar S; Bangash MN; Parekh D; Patel JM
    Anaesthesia; 2021 Oct; 76(10):1358-1366. PubMed ID: 33687732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.